Literature DB >> 1745344

Accelerated intracranial occlusive disease, oral contraceptives, and cigarette use.

S R Levine1, S C Fagan, M S Pessin, R Silbergleit, J Floberg, J F Selwa, C M Vogel, K M Welch.   

Abstract

We report clinical and angiographic features of accelerated intracranial occlusive disease resembling moyamoya vasculopathy in five young women who used oral contraceptives (OCs) and smoked cigarettes, but generally had no other obvious risk factors for cerebrovascular disease. Three women had been on OCs for at least 4 years, one woman each had been on OCs for 3 months and for 2 weeks. All five women had smoked cigarettes for at least eight pack-years. Intermittent and progressive multifocal cognitive, visual, motor, or sensory hemispheric symptoms and signs developed in all. All patients developed strokes, four preceded by transient ischemic attacks. Cerebral angiography demonstrated bilateral supraclinoid internal carotid artery stenosis in four patients and proximal posterior cerebral artery stenosis in one. Additional features included rete mirabile, telangiectasias, prominent lenticulostriate collaterals, and multifocal distal cerebral branch occlusions. Three had mild abnormalities of serum fibrinogen, antinuclear antibody, erythrocyte sedimentation rate, or CSF IgG. After discontinuing OCs and reducing cigarette use, four women have not had further strokes over a mean follow-up of approximately 5 years. In certain young women, clinical and angiographic features resembling moyamoya may develop with the use of OCs and cigarettes. We speculate that an immunologically mediated vasculopathy may explain, in part, this unusual cerebrovascular syndrome in otherwise healthy young women.

Entities:  

Keywords:  Americas; Arterial Occlusive Diseases; Behavior; Biology; Case Studies; Cerebrovascular Effects; Contraception; Contraceptive Agents; Contraceptive Agents, Estrogen; Contraceptive Agents, Female; Contraceptive Methods; Developed Countries; Diseases; Ethinyl Estradiol; Family Planning; Immunity; Immunological Effects; Michigan; Neurologic Effects; North America; Northern America; Oral Contraceptives; Physiology; Research Methodology; Smoking; Studies; United States; Vascular Diseases

Mesh:

Substances:

Year:  1991        PMID: 1745344     DOI: 10.1212/wnl.41.12.1893

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  3 in total

1.  Transcriptomic Profiling of Intracranial Arteries in Adult Patients With Moyamoya Disease Reveals Novel Insights Into Its Pathogenesis.

Authors:  Shuangxiang Xu; Wei Wei; Feiyang Zhang; Tongyu Chen; Lixin Dong; Jichun Shi; Xiaolin Wu; Tingbao Zhang; Zhengwei Li; Jianjian Zhang; Xiang Li; Jincao Chen
Journal:  Front Mol Neurosci       Date:  2022-05-31       Impact factor: 6.261

2.  [Rete compensation in agenesis of the internal carotid artery].

Authors:  H Henkes; J Reinartz; S Fischer; E Miloslavski; G Albes; D Kühne
Journal:  Nervenarzt       Date:  2007-08       Impact factor: 1.214

3.  Moyamoya arteriopathy.

Authors:  Edward R Smith
Journal:  Curr Treat Options Neurol       Date:  2012-12       Impact factor: 3.598

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.